Investing Profile
Charles Kunsch
InvestorVC
Founder and Managing Partner at Ballastone Life Science Advisors
abbvie.comBoston, Massachusetts
Your Intro Paths to Charles Kunsch
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Charles is a member of
Penn State University Network
113 CONNECTIONS
Counter-Strike Network
66 CONNECTIONS
Counter-Strike Network
66 CONNECTIONS
Counter-Strike Network
66 CONNECTIONS
Counter-Strike Network
66 CONNECTIONS
Find Charles Kunsch on
cbCurrent Investing Position
Ballastone Life Science Advisors Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Charles Kunsch is on these Sector & Stage Rankings
Charles Kunsch's Experience
Board Member Medincell S.A.2025 - Present
Board Member Antiverse2025 - Present
Member Board of Trustees Penn State Research Foundation2024 - Present
Member of The Supervisory Board Captor Therapeutics SA2024 - Present
Founder and Managing Partner Ballastone Life Science Advisors2023 - Present
Vice Chair, Member Board Of Trustees Massachusetts Biomedical Initiatives (MBI)2020 - Present
Board Member Village Pizza Tega CayPresent
Member Board of Directors Counter-StrikePresent
Member Board of Directors Endlyz TherapeuticsPresent
Member Board of Directors Stealth Company (Charles Kunsch)Present
Member of The Supervisory Board Counter-StrikePresent
Member Board of Trustees Counter-StrikePresent
Member Board of Trustees Penn State ResearchPresent
Board Member MedincellPresent
Founder & Managing Partner Counter-StrikePresent
Founder and Managing Partner Counter-StrikePresent
Venture Partner DreaventPresent
Board Member NextRNA Therapeutics2025 - 2025
Managing Director, AbbVie Ventures (Retired) AbbVie2013 - 2024
Member Board of Directors Stealth Biotech2023 - 2023
Member Board of Directors Nitrase Therapeutics2023 - 2023
Board Member Quanta Therapeutics2021 - 2023
Member Board of Directors Stealth Mode Biotech2021 - 2023
Member Board of Directors Endlyz UK Limited2021 - 2023
Member Board of Directors FireCyte Therapeutics2021 - 2023
Board Member Kojin Therapeutics2020 - 2023
Board Member Accent Therapeutics, Inc.2020 - 2023
Board Member Disc Medicine2020 - 2022
Board Member Faze Medicines2019 - 2022
Board Member Prevail Therapeutics2019 - 2021
Director, Global External Research AbbVie2009 - 2013
Vice President, Drug Discovery AtheroGenics, Inc.1997 - 2009
Research Scientist Human Genome Sciences1994 - 1997
Post-doctoral Fellow Hoffmann-La Roche1991 - 1993
Charles Kunsch's Education
Drexel University BS Biological Sciencies
Pennsylvania State University College of Medicine PhD Microbiology & Immunology
Penn State University PhD Microbiology & Immunology
Investors who invest with Charles Kunsch
Sign in with Google →Scouts & Angels Affiliated With Charles Kunsch
Sign in with Google →